Skip to main content

Table 3 Gender, race, primary site and cTNM vs. cause of death

From: Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients

  Cause of death   Fisher's exact p-values
  Alive (%) Cardio-respiratory failure (%) Pneumonia (%) Regional met (%) Distant met (%) Total  
Gender        
Male 50 (60.2) 4 (80.0) 0 (0.0) 5 (50.0) 6 (54.5) 65  
Female 33 (39.8) 1 (20.0) 6 (100.0) 5 (50.0) 5 (45.5) 50 0.039
Race        
Caucasian 56 (67.5) 4 (80.0) 5 (83.3) 6 (60.0) 7 (63.6) 78  
Indian 8 (9.6) 0 (0.0) 0 (0.0) 2 (20.0) 0 (0.0) 10  
Middle-Eastern 2 (2.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2  
Oriental 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1  
Other Asians 4 (4.8) 0 (0.0) 0 (0.0) 0 (0.0) 2 (18.2) 6  
African 8 (9.6) 1 (20.0) 1 (16.7) 1 (10.0) 2 (18.2) 13  
Caribbean 4 (4.8) 0 (0.0) 0 (0.0) 1 (10.0) 0 (0.0) 5 0.914
Primary site        
Floor of mouth 16 (19.3) 3 (60.0) 3 (50.0) 0 (0.0) 2 (18.2) 24  
Tongue (lateral) 24 (28.9) 2 (40.0) 0 (0.0) 7 (70.0) 3 (27.3) 36  
Tongue (dorsal) 10 (12.0) 0 (0.0) 1 (16.7) 0 (0.0) 2 (18.2) 13  
Tongue (ventral) 5 (6.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5  
Buccal mucosa 7 (8.4) 0 (0.0) 2 (33.3) 1 (10.0) 1 (9.1) 11  
Hard palate 3 (3.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3  
Upper alveolus 4 (4.8) 0 (0.0) 0 (0.0) 1 (10.0) 1 (9.1) 6  
Lower alveolus 4 (4.8) 0 (0.0) 0 (0.0) 1 (10.0) 1 (9.1) 6  
Retromolar area 2 (2.4) 0 (0.0) 0 (0.0) 0 (0.0) 1 (9.1) 3  
Tuberosity 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1  
Upper lip 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1  
Lower lip 5 (6.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5  
Neck Lump 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 0.819
cTNM        
T1N0M0 54 (65.1) 2 (40.0) 2 (33.3) 1 (10.0) 3 (27.3) 62  
T2N0M0 20 (24.1) 1 (20.0) 2 (33.3) 1 (10.0) 0 (0.0) 24  
T1N1M0 3 (3.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3  
T2N1M0 2 (2.4) 1 (20.0) 1 (16.7) 1 (10.0) 0 (0.0) 5  
T1N2aM0 1 (1.2) 0 (0.0) 0 (0.0) 3 (30.0) 1 (9.1) 5  
T2N2aM0 0 (0.0) 1 (20.0) 1 (16.7) 2 (20.0) 5 (45.5) 9  
T1N2bM0 0 (0.0) 0 (0.0) 0 (0.0) 1 (10.0) 0 (0.0) 1  
T2N2bM0 1 (1.2) 0 (0.0) 0 (0.0) 1 (10.0) 1 (9.1) 3  
T1N2cM0 2 (2.4) 0 (0.0) 0 (0.0) 0 (0.0) 1 (9.1) 3 <0.001
Total 83 5 6 10 11   
Back to article page

Head & Neck Oncology

ISSN: 1758-3284